PharmaCyte Biotech, Inc.
PMCB
$1.21
$0.000.00%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.25M | 22.68M | 26.94M | 333.80K | -1.14M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.71M | -24.52M | -29.60M | -2.78M | -1.01M |
| Change in Net Operating Assets | 185.70K | -100.80K | -206.10K | 298.80K | 43.80K |
| Cash from Operations | -2.27M | -1.94M | -2.87M | -2.15M | -2.11M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.00M | -12.00M | -12.00M | -5.00M | -5.00M |
| Cash from Investing | -7.00M | -12.00M | -12.00M | -5.00M | -5.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 |
| Repurchase of Common Stock | -3.55M | -3.72M | -2.48M | -28.20M | -31.33M |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 35.00M | 35.00M |
| Repurchase of Preferred Stock | -32.01M | -34.93M | -26.94M | -17.51M | -7.99M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 2.26M | 0.00 | 0.00 |
| Cash from Financing | -35.55M | -38.65M | -27.16M | -10.71M | -4.32M |
| Foreign Exchange rate Adjustments | -1.30K | 1.00K | -700.00 | -400.00 | -5.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.83M | -52.59M | -42.03M | -17.86M | -11.43M |